Autopsy report · NCT00333060
Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
Cause of deathNo reason given
Life of this trial
- Registered 7 months after it had already started.
- Ran for about 2 years 2 months before it stopped.
- 164 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Othera Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Epiretinal Membrane; Macular Hole
- Interventions
- OT-551 ophthalmic solution
- Participants
- 164 (planned, not actual)
- Sites
- 16
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.